Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.55 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PDE7A | Q13946 | 4/20 | 0.46 |
| ▸ | PDE7B | Q9NP56 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | ACLY | P53396 | 1/20 | 0.45 |
| ▸ | KIF18A | Q8NI77 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL67536 | 0.87 | MAPK1 (0.53) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL535249 | 0.87 | MAPK1 (0.53) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL29836060 | 0.85 | MAPK1 (0.52) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL535457 | 0.85 | MAPK1 (0.52) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL357928 | 0.85 | PDK1 (0.55) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL67864 | 0.85 | MAPK1 (0.60) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL28325235 | 0.84 | MAPK1 (0.50) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL28859046 | 0.83 | MAPK1 (0.53) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL2112011 | 0.83 | MAPK1 (0.53) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 | |
| SCHEMBL29495064 | 0.83 | MAPK1 (0.53) | ALDH1A1TSHRMAPK1VCAM1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400166-A2 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| EP-3565484-B1 | COMPOSITIONS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | CONTRALINE INC (US) | 2024-04-03 | — | — | EP | claimed |
| EP-3565484-A1 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2019-11-13 | — | — | EP | claimed |
| WO-2018129369-A1 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2018-07-12 | — | — | WO | claimed |
| US-20180185096-A1 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. | 2018-07-05 | — | — | US | claimed |
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | SHELL OIL COMPANY | 2001-11-08 | — | — | US | claimed |
| EP-0128563-B1 | IMPROVED ANTIFOGGANT PROCESS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-04-04 | — | — | EP | claimed |
| EP-0128563-A2 | Improved antifoggant process | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-12-19 | — | — | EP | claimed |
| US-4468454-A | NEGATIVE SILVER HALIDE EMULSIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-08-28 | — | — | US | claimed |
| EP-0045570-B1 | USE OF ORGANIC HALOGEN COMPOUNDS TO REDUCE OR PREVENT FOG IN NEGATIVE-WORKING SILVER HALIDE EMULSIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-09-28 | — | — | EP | claimed |
| US-4323645-A | Organic halogen compounds for negative-working silver halide emulsions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-04-06 | — | — | US | claimed |
| EP-0045570-A1 | Use of organic halogen compounds to reduce or prevent fog in negative-working silver halide emulsions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-02-10 | — | — | EP | claimed |
| US-12383421-B2 | Contraceptive devices | Contraline, Inc. (US) | 2025-08-12 | — | — | US | disclosed |
| CN-120309458-A | Method for synthesizing 2, 4-dichlorobenzaldehyde by using 4-chloro-2-nitrotoluene | 浙江大洋生物科技集团股份有限公司 | 2025-07-15 | — | — | CN | disclosed |
| EP-4400166-A2 | METHODS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | Contraline, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-3565484-B1 | COMPOSITIONS FOR IMPLANTING AND REVERSING STIMULI-RESPONSIVE IMPLANTS | CONTRALINE INC (US) | 2024-04-03 | — | — | EP | disclosed |
| EP-0045570-A1 | Use of organic halogen compounds to reduce or prevent fog in negative-working silver halide emulsions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-02-10 | — | — | EP | disclosed |
| EP-0045570-A1 | Use of organic halogen compounds to reduce or prevent fog in negative-working silver halide emulsions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-02-10 | — | — | EP | disclosed |
| EP-0001585-B1 | PIPERAZINO-PYRROLOBENZODIAZEPINES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CIBA-GEIGY AG (CH) | 1981-07-22 | — | — | EP | disclosed |
| EP-0001585-A1 | Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1979-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | AHR, PAH, HRH3 | ALDH1A1 1723/4885TSHR 1650/4885MAPK1 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.